Publikationen des Medical Device Epidemiology Network (MDEpiNet) Verband Deutschland e.V.

Weitere Veröffentlichungen des globalen Dachverbands finden Sie HIER!

Heidemann F, Peters F, Kuchenbecker J, Kreutzburg T, Sedrakyan A, Marschall U, L’Hoest H, Debus ES, Behrendt CA. Long-term outcomes after revascularizations below the knee with paclitaxel-coated devices – a propensity score matched cohort analysis. Eur J Vasc Endovasc Surg. 2020;60:549-558.

Behrendt CA, Peters F. The paclitaxel files – reasonable doubt or acquittal? VASA. 2021;In Press.

Behrendt CA. Long-term survival with paclitaxel-coated devices – German insurance data. BIBAMedical Charing Cross Textbook. In: Greenhalgh RM (Editor). Charing Cross 2020 – Vascular and Endovascular Challenges Update – Book. BIBA Medical Europe. London, UK. 2020.

Behrendt CA, Sedrakyan A, Peters F, Kreutzburg T, Schermerhorn M, Bertges DJ, et al. Editor´s Choice – Long Term Survival After Femoropopliteal Artery Revascularizations With Paclitaxel-Coated Devices – A propensity score matched cohort analysis. Eur J Vasc Endovasc Surg. 2020;59:587-596.

Behrendt CA, Müller T, Venermo M, Altreuther M, Szeberin Z, Boyle JR, Mani K. The VASCUNET manifesto on data privacy compliant real-world-evidence. Eur J Vasc Endovasc Surg. 2020;60:942-943.

Behrendt CA, Peters F. Re „Methodological approaches to ‘Long Term Survival after Femoropopliteal Artery Revascularisation with Paclitaxel Coated Devices: A Propensity Score Matched Cohort Analysis’“. Eur J Vasc Endovasc Surg. 2020;60:153.

Behrendt CA, Peters F, Mani K. The swinging pendulum of evidence – Is there a reality behind results from randomized trials and real-world data? Lessons learned from the Paclitaxel debate. Eur J Vasc Endovasc Surg. 2020;59:510-511.

Behrendt CA, Debus ES. [The limitations of randomization and the Medical Device Epidemiology Network (MDEPINET)]. Gefässchirurgie. 2019;24:218-219.

Behrendt CA. Routinely collected data from health insurance claims and electronic health records in vascular research – A success story and way to go. VASA. 2020;49:85-86.

Behrendt CA, Björck M, Schwaneberg T, Debus ES, Cronenwett J, Sigvant B. Editor’s Choice – Recommendations for Registry Data Collection for Revascularisations of Acute Limb Ischaemia: A Delphi Consensus from the International Consortium of Vascular Registries. Eur J Vasc Endovasc Surg. 2019;57:816-821.

Behrendt CA, Bertges D, Eldrup N, Beck AW, Mani K, Venermo M, Szeberin Z, Menyhei G, Thomson I, Heller G, Wigger P, Danielsson G, Galzerano G, Lopez C, Altreuther M, Sigvant B, Rieß HC, Sedrakyan A, Beiles B, Björck M, Boyle JR, Debus ES, Cronenwett J. International Consortium of Vascular Registries Consensus Recommendations for Peripheral Revascularization Registry Data Collection. Eur J Vasc Endovasc Surg. 2018;56:217-237.

Behrendt CA, Venermo M, Mani K. Challenges in Europe with Participation in the Vascular Low Frequency Disease Consortium (VLFDC). Vascular News. 2020;Online.

Behrendt CA, Schwaneberg T, Hischke S, Müller T, Petersen T, Marschall U, Debus ES, Kriston L. Data Privacy Compliant Validation of Health Insurance Claims Data – The IDOMENEO Approach. Gesundheitswesen. 2020;82(S02):S94-S100. 10.1055/a-0883-5098.

Sutzko D, Mani K, Behrendt CA, Wanhainen A, Beck AW. Big Data in Vascular Surgery: Registries, International Collaboration and Future Directions. J Int Med. 2020;288:51-61.

Petersen T, Blochberger M, Mueller T, Federrath H, Behrendt CA. [Safe and data privacy compliant realization of medical registries]. Datenschutz und Datensicherheit DuD. 2019;43:507-512.

Behrendt CA, Rother U, Rümenapf G, Uhl C, Görtz H, Böckler D. [Randomized controlled trials and real-world evidence for the market access and surveillance of high-risk products – the example of paclitaxel]. Gefässchirurgie. 2021;In Press. DOI: 10.1007/s00772-020-00726-0.

Peters F, Kreutzburg T, Kuchenbecker J, Marschall U, Remmel M, Dankhoff M, Trute HH, Repgen T, Debus ES, Behrendt CA. [Quality of care in surgical interventional vascular medicine: what can be achieved with routinely collected data from health insurance providers?]. Gefässchirurgie. 2020;In Press. DOI: 10.1007/s00772-020-00679-4.

Behrendt CA, Debus ES, Mani K, Sedrakyan A. The Strengths and Limitations of Claims-based Research in Countries with Fee-for-Service Reimbursement. Eur J Vasc Endovasc Surg. 2018;56:615-616.

Bavendiek K, Müller T, Wittner F, Schwaneberg T, Behrendt CA, Schulz W, Federrath H, Schupp S. Automatically Proving Purpose Limitation in Software Architectures. In: Dhillon G., Karlsson F., Hedström K., Zúquete A. (eds) ICT Systems Security and Privacy Protection. SEC 2019. IFIP Advances in Information and Communication Technology, Volume 562. Springer, Cham. IFIP Advances in Information and Communication Technology. 2019.

Schwaneberg T, Debus ES, Repgen T, Trute H, Müller T, Federrath H, Marschall U, Behrendt CA. [Development of a learning algorithm using real world evidence data – The RABATT study]. Gefässchirurgie. 2019;24:234-238.

Behrendt CA. Blessing or curse of electronic health records – Readmissions following infrarenal AAA repair in electronic health records. VASA. 2019;48:201-202.

Schaaf J, Kadioglu D, Goebel J, Behrendt CA, Roos M, van Enckevort D, Ückert F, Sadiku F, Wagner TOF, Storf H. OSSE Goes FAIR – Implementation of the FAIR Data Principles for an Open-Source Registry for Rare Diseases. Stud Health Technol Inform. 2018;253:209-213.

Debus ES, Kriston L, Schwaneberg T, Hischke S, Rieß HC, Härter M, Marschall U, Federrath H, Behrendt CA. Rationale and Methods of the IDOMENEO Health Outcomes of Peripheral Arterial Disease Revascularisations Study in the GermanVasc Registry. VASA. 2018;47:499-505.

Behrendt CA, Pridöhl H, Schaar K, Federrath H, et al. [Clinical registers in the twenty-first century – balancing act between data protection and feasibility?]. Chirurg. 2017;88:944-949.

Behrendt CA, Heidemann F, Rieß HC, et al. Registry and health insurance claims data in vascular research and quality improvement. VASA. 2017;46:11-15.

Wird fortgesetzt!